Adicet Bio, Inc. (ACET)

Adicet Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-142.66	-69.79	-62	-36.68	-28.14
Depreciation & Amortization	8.94	5.01	4.07	1.95	1.24
Share-Based Compensation	20.26	17.13	12.51	5.26	1.18
Other Operating Activities	19.74	2.89	-5.63	-12.09	-2.16
Operating Cash Flow	-93.72	-44.77	-51.05	-41.55	-27.88
Capital Expenditures	-4.46	-16.78	-13.05	-0.99	-0.95
Acquisitions	0	0	0	64.11	0
Change in Investments	0	0	10.25	52.09	-46.98
Investing Cash Flow	-4.46	-16.78	-2.8	115.22	-47.93
Share Issuance / Repurchase	0.39	45.11	242.95	0.46	0.03
Other Financing Activities	-0.15	-3.6	-0.26	-0.16	76.92
Financing Cash Flow	0.24	41.51	242.69	0.3	76.95
Net Cash Flow	-97.95	-20.04	188.84	73.97	1.13
Free Cash Flow	-98.18	-61.55	-64.1	-42.54	-28.83
Free Cash Flow Margin	-	-246.29%	-658.77%	-237.62%	-2897.89%
Free Cash Flow Per Share	-2.28	-1.50	-2.07	-5.81	-13.48

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).